Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 87 trials
NCI-2020-00752
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Adult (18-64)
Older adult (65+)
CCTG MA.39
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Adult (18-64)
Older adult (65+)
NCI-2013-00500
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Adult (18-64)
Older adult (65+)
ATS23
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Child (birth - 17)
PrE1702
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Adult (18-64)
Older adult (65+)
A222301
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Adult (18-64)
Older adult (65+)
NCI-2022-09876
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Adult (18-64)
Older adult (65+)
NCI-2014-02674
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Adult (18-64)
Older adult (65+)
NRG-BN013
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Adult (18-64)
Older adult (65+)
NCI-2020-05659
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Adult (18-64)
Older adult (65+)